Cadonilimab in the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma

NCT05898256 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma
Immune Checkpoint Inhibitors

Interventions

DRUG: Cadonilimab
DRUG: Gemcitabine
DRUG: Cisplatin

Sponsor

Guangxi Medical University